Breaking out of the silo: One health system's experience

American Journal of Health-System Pharmacy

Volumn 59, Issue SUPPL. 6, 2002, Pages

  Vichiendilokkul, Anna ^a  

^a HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

Anticoagulants; Costs; Dosage schedules; Enoxaparin; Heparins; Pharmacoeconomics; Venous thrombosis

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DEEP VEIN THROMBOSIS; DRUG COST; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL COST; HUMAN; MEDICAL FEE; MONTE CARLO METHOD; PHARMACIST; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0037109037     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/59.suppl_6.s15     Document Type: Conference Paper

References (5)

1. Levine M, Gent M, Hirsh J et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996; 334:677-81.
2. Koopman M, Prandoni P, Piovella F et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med. 1996; 334:682-7.
3. Gould MK, Dembitzer AD, Sanders GD et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep vein thrombosis: a cost-effectiveness analysis. Ann Intern Med. 1999; 130:789-99.
4. Gould MK, Dembitzer AD, Doyle RL et al. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: a meta-analysis of randomized, controlled trials. Ann Intern Med. 1999; 130:800-9.
5. De Lissovoy G, Yusen RD, Spiro TE et al. Cost for inpatient care of venous thrombosis: a trial of enoxaparin vs standard heparin. Arch Intern Med. 2000; 160:3160-5.